Skip to content
Recovery & Performance PeptidesRecovery research and practical context
Source comparison

MOTS-c Pharmacokinetics: Route & Clearance Comparison

Subcutaneous Injection 30–60 minutes 70–85 ~4 hours 5–8 mL/min/kg Standard research route. Predictable absorption, moderate bioavailability, requires daily dosing to maintain plasma levels Intranasal Spray 10–20 minutes 50–65 ~3.5 hours Faster CNS delivery, lo

This comparison does not assign a generated winner or score.

  • Subcutaneous Injection
  • 30–60 minutes
  • 70–85
  • ~4 hours
  • 5–8 mL/min/kg
  • Standard research route. Predictable absorption, moderate bioavailability, requires daily dosing to maintain plasma levels
  • Intranasal Spray
  • 10–20 minutes
  • 50–65
  • ~3.5 hours
  • Faster CNS delivery, lower systemic AUC. Useful for neurometabolic studies but less sustained peripheral effect
  • Intravenous Bolus
  • Immediate (0–5 min)
  • 100
  • Research-only route for precise pharmacokinetic studies. Impractical for repeated dosing outside controlled settings
  • Oral Administration
  • Not applicable
  • <5
  • Non-viable. Peptide bonds hydrolysed by gastric acid and digestive enzymes before absorption; negligible systemic exposure
More references

Related material